image: Microscopic image of a leukemia cancer stem cell with DNA colored in blue and the identifying surface marker CD99 colored in green. This material relates to a paper that appeared in the Jan. 25, 2017, issue of Science Translational Medicine, published by AAAS. The paper, by S.S. Chung at Memorial Sloan Kettering Cancer Center in New York, NY, and colleagues was titled, 'CD99 is a therapeutic target on disease stem cells in myeloid malignancies.' view more
Credit: Montreh Tavakkoli